Menu Search
Equities

Ju Fu Tang Biotech Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
8217:HKG.HS

Ju Fu Tang Biotech Holdings Co Ltd

Actions
  • Price (HKD)0.365
  • Today's Change0.00 / 0.00%
  • Shares traded40.00k
  • 1 Year change+65.91%
  • Beta1.1342
Data delayed at least 15 minutes, as of Feb 13 2026 01:39 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Ju Fu Tang Biotech Holdings Co Ltd, formerly WMHW Holdings Ltd, is an investment holding company mainly engaged in the civil engineering business. The Company mainly engaged in the roads and drainage works including construction and improvement of local road, carriageway with junction improvement and the associated footpaths, planting areas, drains, sewers, water mains and utilities diversion. In addition, the Company is engaged in structural works, site formation works, decoration and renovation works. The Company is engaged in the provision of civil engineering works as a subcontractor.

  • Revenue in HKD (TTM)27.51m
  • Net income in HKD20.24m
  • Incorporated2015
  • Employees22.00
  • Location
    Ju Fu Tang Biotech Holdings Co LtdUnit 2202, 22/F, Causeway Bay Plaza I, 4 Hong KongHKG
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.